Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Lower-than-expected pregnancy loss following flu vaccine, however. HHS wants 18-month hold on FOIA litigation related to ...

Key Takeaways BioNTech is buying fellow German firm CureVac for approximately $1.25 billion as the COVID-19 vaccine maker ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...